Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 Next >
Novo Nordisk's Wegovy weight loss drug approved in China
Tags US: News Biotechnology Business News
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Novo Nordisk A/S Biotechnology Business News
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Zealand Pharma A/S Europe Markets Novo Nordisk A/S
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Biotech and Pharmaceuticals Healthy Returns Novo Nordisk A/S
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Pharmaceuticals Companies Health care industry
From CNBC.com News
European stocks set for muted open after European Central Bank cut
Tags Government and politics Voting Ibex Ltd
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Personal finance Business News Employee benefits
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Eli Lilly and Co Business Health & Science
From CNBC.com News
Cramer's Lightning Round: Apple is a buy
Tags Business News T Rowe Price Group Inc U/S/ Markets
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Eli Lilly and Co Chugai Pharmaceutical Co Ltd stocks
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Novo Nordisk A/S Hospitals Goldman Sachs Group Inc
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Healthy Returns Biotech and Pharmaceuticals Uber Technologies Inc
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
Tags Health & Science Business Medicine
From CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
Tags Breaking News: Technology Technology Health care industry
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Business Eli Lilly and Co Health & Science
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Biotech and Pharmaceuticals Healthy Returns Science
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Pharmaceuticals Companies Health care industry
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Eli Lilly and Co Apple Inc Health & Science
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Science Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags Health care industry Pharmaceuticals Companies
From CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
Tags Business News Earnings Biotechnology
From CNBC.com News
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
Tags Earnings Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
Tags Novo Nordisk A/S Breaking news Biotech and Pharmaceuticals
From CNBC.com News
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
Tags Social issues Health & Science Breaking News: Politics
From CNBC.com News
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
Tags Business Social issues Health & Science
From CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
Tags CAVA Group Inc US: News Starbucks Corp
From CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
Tags Health & Science Eli Lilly and Co Business
From CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
Tags Health care industry Pharmaceuticals Companies
From CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Breaking news
From CNBC.com News
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
Tags Business News Biotechnology US: News
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.